Who owns Novavax?

Key details on Novavax (Ticker: NVAX)

Who owns Novavax?

Is NVAX a good stock to own? Find out who bought Novavax, who sold Novavax (NVAX) stock, and who holds a large position in Novavax.

Fund Name Number of Shares Share Valuation As Of
FMR 32.24M $227.93M Sept. 30, 2015
T. Rowe Price Associates 21.31M $150.66M Sept. 30, 2015
Vanguard 17.63M $124.84M Sept. 30, 2015
First Trust Advisors 13.53M $113.48M Dec. 31, 2015
BlackRock Fund Advisors 10.44M $73.80M Sept. 30, 2015
Wellington Management Company 8.76M $61.96M Sept. 30, 2015
BB Biotech AG 8.33M $58.89M Sept. 30, 2015
STATE STREET CORPORATION 7.17M $50.71M Sept. 30, 2015
BlackRock Institutional Trust Company, N.A. 6.78M $47.92M Sept. 30, 2015
Inves 6.37M $45.03M Sept. 30, 2015
Camber Capital Management 4.75M $19.81M Sept. 30, 2014
HealthCor Management 4.60M $23.55M Dec. 31, 2013
Wells Fargo & Company 3.38M $23.92M Sept. 30, 2015
RA Capital Management 3.24M $19.22M Dec. 31, 2014
NORTHERN TRUST 3.16M $34.72M Sept. 30, 2015
Ameriprise Financial 3.07M $21.72M Sept. 30, 2015
Franklin Resources 3.04M $21.51M Sept. 30, 2015
BlackRock Advisors 2.93M $6.01M June 30, 2013
Ayer Capital Management 2.77M $5.24M Dec. 31, 2012
NorthPointe Capital 2.26M $13.40M Dec. 31, 2014
GOLDMAN SACHS 2.20M $4.17M Dec. 31, 2012
Baker Bros. Advisors 2.20M $15.52M Sept. 30, 2015
EVENTIDE ASSET MANAGEMENT 2.10M $14.83M Sept. 30, 2015
BNP PARIBAS INVESTMENT PARTNERS S.A. 2.06M $17.08M March 31, 2015

Who sold Novavax?

Fund Name Date Sold Number of Shares Sold Share Valuation
VHCP Management Dec. 31, 2010 4.56M $11.07M